PRKCD and metabolic dysfunction-associated steatohepatitis: As a member of the PKC family, increased PKCδ activation has been observed in the liver tissue of NASH mice and the human hepatic cell line L02 treated with PA (Lai et al., 2017; Koh et al., 2021).